Novel Tumor-associated Antigen of Hepatocellular Carcinoma Defined by Monoclonal Antibody E4-65
Authors:
Open Access
- 1 May 2007
- journal article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 39 (5) , 359-365
Abstract
A monoclonal antibody, E4-65, produced by immunizing mice with SMMC-7721 cells, a human hepatocellular carcinoma (HCC) cell line, was used to identifKeywords
This publication has 15 references indexed in Scilit:
- Principles and use of anti-CTLA4 antibody in human cancer immunotherapyCurrent Opinion in Immunology, 2006
- Serum tumor markers for detection of hepatocellular carcinomaWorld Journal of Gastroenterology, 2006
- The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cellsThe International Journal of Biochemistry & Cell Biology, 2006
- Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancerClinical Therapeutics, 2005
- Monoclonal antibodies as effective therapeutic agents for solid tumorsCancer Science, 2004
- HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domainsCellular and Molecular Life Sciences, 2004
- Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinomaBiochemistry and Cell Biology, 2004
- Senescence Marker Protein-30 Knockout Mouse Liver Is Highly Susceptible to Tumor Necrosis Factor-α- and Fas-Mediated ApoptosisThe American Journal of Pathology, 2002
- Plasma Des–γ–Carboxyprothrombin in the Early Stage of Hepatocellular CarcinomaHepatology, 1990
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989